Table 1 Drug classes receiving co-payment reductions: focus on diabetes trial
From: A controlled trial of value-based insurance design – The MHealthy: Focus on Diabetes (FOD) trial
Glycemic Agents |
|---|
Metformin |
Sulfonylureas |
Thiazolidinediones |
All other glycemic agents (except insulin*) |
Antihypertensive Agents |
ACE-Inhibitors & Angiotensin Receptor Blockers (ACE/ARB) |
Beta blockers |
Calcium Channel Blockers |
Diuretics |
Other antihypertensives |
Lipid-Lowering Agents |
HMG-CoA Reductase Inhibitors (statins) |
Zetia |
Other lipid lowering agents |
Antidepressants |
SSRSs/SNRIs |
Tricyclic agents |
Other antidepressants |